TY - JOUR
T1 - Allogeneic transfusion risks in the surgical patient
AU - Klein, H. G.
PY - 1995
Y1 - 1995
N2 - The risk of blood transfusion-associated complications has been reduced in the past 10 years through technical advances in testing of blood, viral inactivation of noncellular blood components, enforcement of stringent donor selection criteria, and the use of alternatives to allogeneic transfusion. Even so, a zero-risk blood supply is unfeasible. The general public perceives infectious complications to be the most significant risk: although the greatest fear is associated with transmission of human immunodeficiency virus (HIV), at least three hepatitis viruses are transmissible by all blood components. Human immunodeficiency virus accounts for
AB - The risk of blood transfusion-associated complications has been reduced in the past 10 years through technical advances in testing of blood, viral inactivation of noncellular blood components, enforcement of stringent donor selection criteria, and the use of alternatives to allogeneic transfusion. Even so, a zero-risk blood supply is unfeasible. The general public perceives infectious complications to be the most significant risk: although the greatest fear is associated with transmission of human immunodeficiency virus (HIV), at least three hepatitis viruses are transmissible by all blood components. Human immunodeficiency virus accounts for
UR - http://www.scopus.com/inward/record.url?scp=0029563170&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029563170&partnerID=8YFLogxK
U2 - 10.1016/S0002-9610(99)80054-3
DO - 10.1016/S0002-9610(99)80054-3
M3 - Article
C2 - 8546242
AN - SCOPUS:0029563170
SN - 0002-9610
VL - 170
JO - American Journal of Surgery
JF - American Journal of Surgery
IS - 6 SUPPL.
ER -